Anti-hepatitis C virus antibody prevails in fulminant hepatic failure
✍ Scribed by Muto, Yasutoshi ;Sugihara, Jun′ichi ;Ohnishi, Hiroo ;Moriwaki, Hisataka ;Nishioka, Kusuya
- Publisher
- Springer-Verlag
- Year
- 1990
- Tongue
- English
- Weight
- 262 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0435-1339
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The role of hepatitis C virus (HCV) infection in fulminant hepatic failure is controversial. The frequency of serum HCV RNA positivity in previously reported patients with fulminant hepatic failure (FHF) of indeterminate cause ranged from 0 to 12% in the United States and Europe and from 43% to 59%
## Abstract The prevalence of hepatitis delta virus (HDV) infection was studied in 25 adult patients with fulminant hepatitis who were admitted consecutively to our unit from February, 1986, to September, 1988. Enzyme and radioimmunoassays were used for the detection of serological markers of HAV,
## Abstract Antihepatitis C virus (HCV) IgM antibodies were found in patients with both acute and chronic hepatitis C. The aims of the study were to determine the significance, in terms of liver disease and virological parameters, of anti‐HCV core IgM antibodies in the serum of patients with chroni